Artelo Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	4	4	8	22	4	7
Market Cap Growth	-27.90%	-45.90%	-63.01%	416.89%	-34.93%	-
Enterprise Value	-3	-6	-9	12	2	2
PE Ratio	-	-0.48	-0.82	-3.00	-0.93	-3.05
PB Ratio	0.45	0.38	0.43	1.85	1.11	1.22
P/FCF Ratio	-0.53	-0.54	-1.03	-3.63	-0.99	-2.37
P/OCF Ratio	-0.53	-0.54	-1.03	-3.63	-0.99	-2.38
EV/EBITDA Ratio	0.28	0.64	0.92	-1.66	-0.47	-1.02
EV/EBIT Ratio	0.28	0.64	0.91	-1.66	-0.47	-1.02
EV/FCF Ratio	0.30	0.72	1.15	-2.01	-0.50	-0.79
Debt / Equity Ratio	0.01	0.00	0.00	0.01	-	-
Debt / EBITDA Ratio	-0.01	0.00	-0.01	-0.01	-	-
Debt / FCF Ratio	-0.01	0.00	-0.01	-0.02	-	-
Quick Ratio	10.55	8.08	17.57	19.13	4.28	4.33
Current Ratio	11.36	8.51	18.36	19.61	4.67	4.35
Interest Coverage	-	-	-2015.60	-	-	-
Return on Equity (ROE)	-73.70%	-61.70%	-44.40%	-93.40%	-118.10%	-196.20%
Return on Assets (ROA)	-68.90%	-58.10%	-42.90%	-87.40%	-106.00%	-104.90%
Return on Capital (ROIC)	-105.83%	-84.33%	-52.85%	-61.31%	-120.93%	-58.77%
Earnings Yield	-225.42%	-208.06%	-122.17%	-33.33%	-107.84%	-32.74%
FCF Yield	-210.37%	-183.83%	-97.03%	-27.52%	-100.71%	-42.11%
Buyback Yield / Dilution	-11.94%	-4.48%	-127.55%	-403.69%	-70.67%	-70.05%
Total Shareholder Return	-11.94%	-4.48%	-127.55%	-403.69%	-70.67%	-70.05%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).